Reviewing the regulatory barriers for nanomedicine: Global questions and challenges

Diana Bowman, Jake Gatof

Research output: Contribution to journalArticle

9 Scopus citations

Abstract

Nanomedicine will play an increasing role in prevention and treatment across the entire healthcare spectrum. However, their precise market size, economic value and areas of application remain unclear. This opacity, including the question of what constitutes nanomedicine matters, especially when considered alongside the key regulatory questions and concerns. This article begins by placing these key questions into context in relation to the current scientific state of the art, focusing particular attention on the human health and safety context. In exploring these central questions surrounding the regulation of nanomedicine, this perspective also explores existing and suggested frameworks that aim to deal with emerging technologies more generally. It then outlines priority areas for action and general conclusions specific to nanomedicine.

Original languageEnglish (US)
Pages (from-to)3275-3286
Number of pages12
JournalNanomedicine
Volume10
Issue number21
DOIs
StatePublished - Nov 1 2015

Keywords

  • EU
  • global challenges
  • governance
  • health and safety
  • innovation
  • intellectual property
  • nanomaterials
  • regulation
  • USA

ASJC Scopus subject areas

  • Materials Science(all)
  • Bioengineering
  • Biomedical Engineering
  • Medicine (miscellaneous)
  • Development

Fingerprint Dive into the research topics of 'Reviewing the regulatory barriers for nanomedicine: Global questions and challenges'. Together they form a unique fingerprint.

  • Cite this